Serum miR-214 as a novel biomarker for ankylosing spondylitis.
Hyun Yi KookSo-Hee JinPu-Reum ParkSeung-Jin LeeHong-Joon ShinTae Jong KimPublished in: International journal of rheumatic diseases (2019)
miR-214 may serve as a noninvasive biomarker for diagnosis of AS. In addition, expression level of miR-214 was associated with disease activity.